Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea

Last updated: March 13, 2025
Sponsor: Chang Gung Memorial Hospital
Overall Status: Completed

Phase

2

Condition

Rosacea

Treatment

dian dao san

Clinical Study ID

NCT05045469
202101000A3
  • Ages > 20
  • All Genders

Study Summary

The aim of this study is to investigate the effects of topical herbal medicine in the patients with rosacea.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Willing to sign inform consent

  • Aged above 20 years old with rosacea

  • No treatment for rosacea within 2 weeks

Exclusion

Exclusion Criteria:

  • With malignant lesion in the rosacea lesion

  • Rosacea lesion with high risk of infection

  • Allergy to Chinese herbal medicine patch or ointment

  • Pregnancy

Study Design

Total Participants: 24
Treatment Group(s): 1
Primary Treatment: dian dao san
Phase: 2
Study Start date:
August 04, 2021
Estimated Completion Date:
August 04, 2024

Study Description

Rosacea is a chronic inflammatory disorder which affects the cheek, nose, chin, forehead and eyes. It is typically characterized by cutaneous signs such as flushing, erythema, telangiectasia, papules, and pustules in the face. The pathogenic mechanism of rosacea is unknown, and there is no cure for rosacea. The therapeutic approaches include oral medicine, topical medicine and surgical interventions depending on the different subtypes of rosacea. The recent study demonstrates that combination therapy may be more effectively improved the symptoms of rosacea. Dian dao san is a topical herbal compound for reducing the features as flushing, erythema, papules, and pustules for years. The investigators hypothesize that dian dao san can be more beneficial in treating the patients with rosacea and improving the quality of life.

Connect with a study center

  • Keelung Chang Gung Memorial Hospital

    Keelung,
    Taiwan

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.